- Home
- IMRX vs SRV Comparison
IMRX vs SRV Comparison
Compare IMRX & SRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRX
- SRV
- Stock Information
- Founded
- IMRX 2008
- SRV 2007
- Country
- IMRX United States
- SRV United States
- Employees
- IMRX N/A
- SRV N/A
- Industry
- IMRX Biotechnology: Pharmaceutical Preparations
- SRV Finance Companies
- Sector
- IMRX Health Care
- SRV Finance
- Exchange
- IMRX Nasdaq
- SRV Nasdaq
- Market Cap
- IMRX 232.9M
- SRV 191.0M
- IPO Year
- IMRX 2021
- SRV N/A
- Fundamental
- Price
- IMRX $7.49
- SRV $41.06
- Analyst Decision
- IMRX Strong Buy
- SRV
- Analyst Count
- IMRX 5
- SRV 0
- Target Price
- IMRX $17.20
- SRV N/A
- AVG Volume (30 Days)
- IMRX 1.2M
- SRV 33.9K
- Earning Date
- IMRX 11-12-2025
- SRV 01-01-0001
- Dividend Yield
- IMRX N/A
- SRV 13.38%
- EPS Growth
- IMRX N/A
- SRV N/A
- EPS
- IMRX N/A
- SRV N/A
- Revenue
- IMRX N/A
- SRV N/A
- Revenue This Year
- IMRX N/A
- SRV N/A
- Revenue Next Year
- IMRX N/A
- SRV N/A
- P/E Ratio
- IMRX N/A
- SRV N/A
- Revenue Growth
- IMRX N/A
- SRV N/A
- 52 Week Low
- IMRX $1.10
- SRV $30.73
- 52 Week High
- IMRX $10.08
- SRV $44.30
- Technical
- Relative Strength Index (RSI)
- IMRX 62.47
- SRV 33.82
- Support Level
- IMRX $6.62
- SRV $42.75
- Resistance Level
- IMRX $7.50
- SRV $43.50
- Average True Range (ATR)
- IMRX 0.62
- SRV 1.04
- MACD
- IMRX 0.08
- SRV -0.09
- Stochastic Oscillator
- IMRX 91.19
- SRV 0.15
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
About SRV NXG Cushing Midstream Energy Fund of Beneficial Interest
NXG Cushing Midstream Energy Fund is a non-diversified, closed-end management investment company with an investment objective of seeking a high after-tax total return from a combination of capital appreciation and current income. The fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in midstream energy investments.